In our fast-paced world, the healthcare industry is no different in its quest to quickly and successfully transition patients through their ‘continuum of care’. Unfortunately, many times there is a knowledge gap between patient/caretaker and their respective provider, nurse, or physician. In this episode, Vynamic tries to tackle these issues and discuss the differences between ‘lowercase a’ advocates, and “capital A” Advocacy to find some solutions to mitigate these risks. Special guest and friend of Vynamic, Dr. David Fajgenbaum, stops by to tell us his amazing story of advocacy around a disease that he was diagnosed with; one that almost killed him.
Resources
https://www.ncbi.nlm.nih.gov/pubmed/24841071
https://www.academyhealth.org/files/RapidEvidenceReviewConsumerEngagementFinal2.pdf
20 September 2018
Discover how pharmaceutical companies can enhance patient experience and interoperability through direct-to-patient (DTP) models.
Read moreLaunchNav by Inizio simplifies pharma launches with AI-driven insights, real-time benchmarks, and 800+ launch learnings.
Read moreOBBBA reshapes U.S. healthcare with $1.2T cuts, shifting risk to providers, payers, and pharma. Explore impacts and strategies.
Read more